Evidence map›Paper›PMID 37606392›Full record

ArticleNeurology international2023

Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome.

Takayoshi Akimoto, Makoto Hara, Satoshi Hirose, Kazuo Nakamichi, Hideto Nakajima

Open access · goldAbstract readCase Reports
In one paragraph

Article in Neurology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Takayoshi AkimotoDivision of Neurology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.ORCID 0000-0002-3390-5792
Makoto HaraDivision of Neurology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.
Satoshi HiroseDivision of Neurology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.
Kazuo NakamichiDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.ORCID 0000-0001-7594-2607
Hideto NakajimaDivision of Neurology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.ORCID 0000-0002-2154-9196
Nihon University · JPNational Institute of Infectious Diseases · JP

Funding

Japan Society for the Promotion of Science 21K07450Japan Society for the Promotion of Science JP20K07875Ministry of Health Labour and Welfare 22HA1003
6 · The paper itself

Abstract

A 58-year-old woman with a history of systemic lupus erythematosus (SLE) who was taking prednisolone and mycophenolate mofetil presented with gait disturbances that progressively worsened over a period of 3 months. Her blood test and cerebrospinal fluid (CSF) examination results did not indicate active SLE. Initial brain magnetic resonance imaging (MRI) revealed a small spotty lesion in the left cerebellar peduncle. The clinical course was consistent with rapidly progressive cerebellar syndrome (RPCS), which sometimes involves neuronal antibodies. The line blot assay detected anti-Yo antibodies, but no malignancy was found. Immunohistological techniques using rat brain sections yielded a negative result for anti-Yo antibodies. The second MRI revealed a focal lesion and surrounding spotty lesion in the left cerebellar peduncle, which was consistent with the punctate pattern observed in progressive multifocal leukoencephalopathy (PML). The CSF JCV-DNA test indicated the presence of cerebellar PML. Immunosuppressants were reduced, and mefloquine and mirtazapine were initiated. After approximately 2 years and 1 month, the CSF JCV-DNA results became negative. Cerebellar PML may exhibit a clinical course that is consistent with RPCS. The punctate pattern should be recognized as an early manifestation of PML. The CSF JCV-DNA copy number may serve as a useful indicator of PML stabilization.

Indexed as

anti-Yo antibodycerebellar ataxiaprogressive multifocal leukoencephalopathyrapidly progressive cerebellar syndromesystemic lupus erythematosus

Identifiers

PMID37606392
PMCPMC10443244
OpenAlexW4385320002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.